Being told that you need a breast biopsy can be frightening, but a biopsy recommendation does not mean that breast cancer has already been diagnosed. It means that a breast lump or imaging abnormality needs tissue analysis to determine what it actually is.
The American Cancer Society states that a biopsy is the only way to know for certain whether an abnormal breast area contains cancer cells. At the same time, most breast biopsy results are not cancer. [1]
A breast biopsy is a procedure that removes a small sample of breast tissue from an abnormal area so that it can be examined in a laboratory by a pathologist.
The sample may be obtained with a thin needle, a larger hollow core needle or, less commonly, through a surgical biopsy. [1]
In most needle biopsies, the purpose is not to remove the entire abnormality. It is to obtain enough tissue to determine what is happening at a cellular level.
A biopsy may be recommended when clinical examination or breast imaging identifies an abnormality that cannot be confidently classified as benign.
Examples include:
Imaging describes how an area looks. Biopsy answers a different question: what is the tissue actually made of?
No.
A biopsy is recommended because imaging or examination cannot provide a sufficiently certain answer. The American Cancer Society notes that most breast biopsy results are not cancer. [1]
The pathology result might show:
Evidence does not support the common belief that standard breast biopsy causes cancer to spread through the body.
The National Cancer Institute states that the chance that tumour biopsy or surgery will cause cancer to spread to other parts of the body is extremely low. Standard medical techniques are designed to minimise this risk. [2]
Avoiding a necessary biopsy because of this fear can be more harmful, because it may delay diagnosis and appropriate treatment if cancer is present.
Fine needle aspiration uses a very thin needle to withdraw fluid or groups of cells. It can be useful in selected situations but generally provides less tissue than a core needle biopsy. [3]
A core needle biopsy uses a hollow needle to remove several small cylinders of tissue.
The American Cancer Society describes core needle biopsy as often the preferred type of biopsy when breast cancer is suspected because it obtains more tissue than fine needle aspiration without requiring open surgery. [4]
A vacuum-assisted device can obtain multiple tissue samples through a single needle insertion and can be useful for selected imaging abnormalities.
A surgical biopsy removes part or all of an abnormal area through an incision.
Most patients who require breast biopsy can undergo a needle procedure rather than surgery. Surgical biopsy is reserved for situations in which needle sampling is not appropriate or has not provided a sufficiently clear answer. [1]
When an abnormal area cannot be reliably targeted by touch, imaging is used to guide the biopsy needle precisely to it.
| Guidance method | When it may be used |
|---|---|
| Ultrasound | When the mass or abnormality is clearly visible on ultrasound, allowing real-time needle guidance. |
| Stereotactic / mammographic guidance | Particularly useful for microcalcifications or abnormalities visible on mammography but not clearly seen on ultrasound. |
| MRI guidance | Used for abnormalities that are visible on MRI but cannot be adequately targeted with mammography or ultrasound. |
RadiologyInfo notes that stereotactic biopsy is particularly useful for small clusters of calcifications and abnormalities not visible on ultrasound, while MRI-guided biopsy is used for findings best seen on MRI. [5] [6]
Most needle breast biopsies are performed using local anaesthetic.
You may feel a brief sting when the anaesthetic is injected. Once the area is numb, pressure or movement may be more noticeable than sharp pain while samples are taken. [3]
Afterward, temporary soreness, bruising, swelling or minor bleeding at the biopsy site can occur.
A very small tissue marker or clip may be placed at the biopsy site.
Its purpose is to mark the exact area that was sampled so that it can be found on future imaging or during treatment if necessary.
The American Cancer Society notes that the marker is usually not visible or noticeable to the patient, can remain in place, is safe during MRI examinations and does not set off standard metal detectors. [4]
Tell your healthcare team about:
Follow the specific instructions given by your healthcare team.
After a needle biopsy, you may be advised to:
Bruising and mild swelling are common after core needle biopsy and can temporarily make the area appear larger. These usually improve with time. [4]
Contact the healthcare team if you develop persistent bleeding, rapidly increasing swelling, worsening pain, increasing redness or warmth, discharge from the biopsy site or fever.
There is no universal turnaround time for every breast biopsy.
The American Cancer Society notes that results typically take at least several days. Additional testing can make the final pathology report take longer. [1]
If breast cancer is identified, further tests on the tissue may include hormone receptor and HER2 testing, which can add information needed for treatment planning.
| Possible result | What it may mean |
|---|---|
| Benign | No cancer is identified; follow-up may be all that is needed if the pathology explains the imaging finding. |
| Atypical or high-risk lesion | Not necessarily cancer but may require additional assessment, surveillance or excision depending on the diagnosis. |
| In situ disease | Abnormal or malignant cells remain within the structure where they began, such as DCIS. |
| Invasive breast cancer | Cancer cells have invaded surrounding tissue and further characterisation is required to plan treatment. |
If invasive breast cancer is found, the biopsy tissue is commonly tested for estrogen receptors ER, progesterone receptors PR and HER2, among other tests when appropriate. These results can directly influence treatment choices. [7]
A benign pathology result needs to make sense in the context of the imaging and clinical examination.
Core needle biopsy provides a clear answer in most cases, but it can occasionally miss a cancer. The American Cancer Society notes that if the result is inconclusive or the doctor remains concerned, another core biopsy or a more extensive surgical biopsy may be needed. [4]
No.
BI-RADS is the standard system radiologists use to describe breast imaging findings and recommend the next step. Some categories require only routine screening, some call for short-term follow-up, while more suspicious categories are more likely to lead to a biopsy recommendation.
A breast biopsy does not mean that cancer has already been diagnosed. It is the procedure used to obtain tissue when examination and imaging cannot determine the nature of an abnormal area with enough certainty.
Most breast biopsies can be performed with a needle and local anaesthetic rather than surgery. Core needle biopsy is commonly used when breast cancer is suspected because it provides enough tissue for diagnosis and additional laboratory tests.
Current medical evidence also does not support the belief that routine breast biopsy “opens” a tumour or causes cancer to spread. The chance of biopsy causing cancer spread is extremely low.
If cancer is found, the tissue provides information beyond the diagnosis itself, including tumour type, grade, ER and PR receptor status and HER2 status. These findings help guide treatment.
If pathology is benign but does not adequately explain a suspicious imaging finding, further evaluation may still be necessary.